Urology · Rockville, MD
NPI
1053419614
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9420 Key West Ave., #420
Rockville, MD, 20850
Phone (301) 258-1919
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
9,047 services
Medicare patients, 2024
750
Average age 76
Drug cost, 2024
$254K
2,045 prescriptions
Company payments, 2025
$1,223
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto Pedraza was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 807 times for 561 patients. In total Roberto Pedraza billed 9,047 services in 73 codes, and Medicare paid $245K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-09-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 807 | 561 | $12.91 | $10K |
| 81003 Clinical Chemistry | Office | 681 | 519 | $2.18 | $1,486 |
| 99214 Office E&M - Established | Office | 436 | 352 | $94.85 | $41K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 407 | 59 | $49.97 | $20K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 388 | 56 | $52.08 | $20K |
| 99213 Office E&M - Established | Office | 357 | 290 | $74.64 | $27K |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 255 | 237 | $85.39 | $22K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 126 | 102 | $48.72 | $6,138 |
| 52000 Cystourethroscopy | Facility | 124 | 112 | $66.11 | $8,198 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 123 | 40 | $41.11 | $5,056 |
| 51798 Ultrasound - Nonspecific | Office | 101 | 94 | $9.68 | $977 |
| 36415 Venipuncture Blood Collection | Office | 92 | 81 | $8.56 | $787 |
| 99427 Chronic, Principal, and Transitional Care Management | Office | 77 | 32 | $33.85 | $2,606 |
| 99204 Office E&M - New | Office | 73 | 73 | $125.92 | $9,192 |
| 51741 Test - Miscellaneous | Office | 60 | 58 | $11.34 | $681 |
By year: 2022 $264K for 5,749 services; 2023 $228K for 5,648 services; 2024 $245K for 9,047 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 681 | 519 | $2.18 | $1,486 |
| 36415 Venipuncture Blood Collection | 92 | 81 | $8.56 | $787 |
Medicare prescription drug claims, 2024
In 2024, the drug Roberto Pedraza prescribed most often to Medicare patients was Tamsulosin Hcl, with 493 prescriptions and refills. In total Roberto Pedraza wrote 2,045 Medicare prescriptions that cost $254K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 493 | 1,337 | 159 | $11K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 301 | 856 | 110 | $8,064 |
| Dutasteride Generic | 287 | 818 | 98 | $15K |
| Finasteride Generic | 144 | 430 | 46 | $2,641 |
| Myrbetriq Mirabegron | 113 | 285 | 42 | $126K |
| Levofloxacin Generic | 82 | 82 | 65 | $194 |
| Silodosin Generic | 76 | 223 | 33 | $9,367 |
| Doxycycline Monohydrate Generic | 65 | 65 | 57 | $1,214 |
| Dutasteride-Tamsulosin Dutasteride/Tamsulosin Hcl | 47 | 137 | 15 | $11K |
| Cefuroxime Cefuroxime Axetil | 43 | 43 | 37 | $245 |
| Estradiol Generic | 34 | 81 | 21 | $2,610 |
| Celecoxib Generic | 30 | 30 | 28 | $221 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 28 | 28 | 13 | $296 |
| Gemtesa Vibegron | 28 | 82 | 12 | $44K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 59 | 14 | $209 |
Brand drugs: - claims; generic drugs: 1,880 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto Pedraza $1,223 ($1,223 in general payments such as food, travel and fees) from 22 companies. The largest payer was Sumitomo Pharma America, Inc. with $292.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 14 | $292 |
| Immunitybio, Inc. IBRX | 1 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $114 |
| Abbvie Inc. ABBV | 4 | $103 |
| Endo USA, Inc. | 3 | $77.97 |
| Urogen Pharma, Inc. URGN | 3 | $67.33 |
| Antares Pharma, Inc. | 2 | $53.55 |
| Teleflex LLC TFX | 1 | $44.19 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $35.06 |
| Astellas Pharma US Inc 4503.T | 1 | $31.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.